Premium
Pyrazinamide induced hepatic injury in rats through inhibiting the PPARα pathway
Author(s) -
Zhang Yun,
Guo Hongli,
Hassan Hozeifa M.,
Ding Pingping,
Su Yijing,
Song Yuming,
Wang Tao,
Sun Lixin,
Zhang Luyong,
Jiang Zhenzhou
Publication year - 2016
Publication title -
journal of applied toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.784
H-Index - 87
eISSN - 1099-1263
pISSN - 0260-437X
DOI - 10.1002/jat.3319
Subject(s) - liver injury , fenofibrate , pyrazinamide , peroxisome proliferator activated receptor , peroxisome , pharmacology , chemistry , receptor , intracellular , lipid metabolism , medicine , endocrinology , biochemistry , rifampicin , antibiotics
Pyrazinamide (PZA) causes serious hepatotoxicity, but little is known about the exact mechanism by which PZA induced liver injury. The peroxisome proliferator‐activated receptors alpha (PPARα) is highly expressed in the liver and modulates the intracellular lipidmetabolism. So far, the role of PPARα in the hepatotoxicity of PZA is unknown. In the present study, we described the hepatotoxic effects of PZA and the role of PPARα and its target genes in the downstream pathway including L‐Fabp, Lpl, Cpt‐1b, Acaa1, Apo‐A1 and Me1 in this process. We found PZA induced the liver lipid metabolism disorder and PPARα expressionwas down‐regulated which had a significant inverse correlation with liver injury degree. These changeswere ameliorated by fenofibrate, the co‐treatment that acts as a PPARα agonist. In contrast, short‐termstarvation significantly aggravated the severity of PZA‐induced liver injury. In conclusion, this study demonstrated the critical role played by PPARα in PZA‐induced hepatotoxicity and provided a better understanding of the molecular mechanisms underlying PZA‐induced liver injury. Copyright © 2016 John Wiley & Sons, Ltd.